Research is key to future treatment
The BRC is a partnership between The Royal Marsden and The Institute of Cancer Research, London. It supports innovative translational research, taking leading-edge cancer research from the laboratory and rapidly translating it into a clinical setting.
What does the future hold for gynaecological cancers & sarcoma?
Register now for our patient & public engagement event on Tuesday 8 October 2019.
Latest news
News
A major new study reveals that bowel cancer patients who have become resistant to a widely used targeted treatment could benefit from immunotherapy.
Find out more
News
A new two-in-one drug, which delivers chemotherapy directly to cancer cells, can extend life for women with HER2+ breast cancer known who have stopped responding to other treatments.
Find out more
News
A recent clinical trial has found a pioneering gene-targeted drug designed for breast cancer to be effective in 80 percent of men with BRCA-mutant prostate cancer
Find out more